Related Experiment Video
Updated: Mar 19, 2026

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Gram-negative prosthetic joint infections managed according to a multidisciplinary standardized approach: risk
O Grossi1, N Asseray2, C Bourigault3
1Service des Maladies Infectieuses, Centre Hospitalier Universitaire, 1 place Alexis Ricordeau, 44093 Nantes cedex 1, France Département de Médecine Interne - Infectiologie, Nouvelles Cliniques Nantaises, 3 rue Eric Tabarly, 44277 Nantes cedex 2, France ogrossi@ncn.fr.
Objectives:
To describe the outcome and risk factors for treatment failure of 76 Gram-negative bacilli (GNB) prosthetic joint infections (PJIs) managed with a curative intent according to a standardized protocol derived from published guidelines.
Methods:
We analysed data from all the cases of GNB-PJI treated surgically over an 8 year period. Treatment failure was defined as persistence or recurrence of PJI signs during follow-up, resulting in additional surgery and/or antibiotic administration or death.
Results:
Treatment failure within the follow-up period (median = 2.6 years) was observed in 16 of 76 (21.1%) patients. The failure rate was similar whether the patients were treated with fluoroquinolones in the whole cohort (22.4% versus 16.7%, P = 0.75) and after stratification according to the surgical procedure. The low failure rate observed in patients not receiving fluoroquinolones might be explained by the standardized attitude of maintaining intravenous β-lactams throughout treatment duration (median = 90 days). In multivariate analysis, C-reactive protein level ≥175 mg/L was significantly associated with treatment failure (adjusted HR = 7.75, 95% CI = 2.66-22.59, P < 0.0001).
Conclusions:
Management according to standardized procedures may improve the prognosis of GNB-PJI. Intravenous β-lactams, continued for 3 months, should be considered an effective alternative to fluoroquinolones.
Insights
Standardized treatment for Gram-negative bacilli prosthetic joint infections (GNB-PJIs) shows promising outcomes. High C-reactive protein levels (≥175 mg/L) predict treatment failure, suggesting careful monitoring is crucial for GNB-PJI management.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Pharmacology
Background:
- Prosthetic joint infections (PJIs) caused by Gram-negative bacilli (GNB) present significant treatment challenges.
- Standardized treatment protocols are essential for managing GNB-PJIs effectively.
Purpose of the Study:
- To evaluate the outcomes and identify risk factors for treatment failure in GNB-PJIs managed with curative intent.
- To assess the efficacy of different antibiotic strategies, including fluoroquinolones and intravenous β-lactams.
Main Methods:
- A retrospective analysis of 76 patients with GNB-PJI treated surgically over an 8-year period.
- Treatment failure was defined by persistent/recurrent infection signs, requiring further intervention or leading to death.
- Multivariate analysis was used to identify predictors of treatment failure.
Main Results:
- A treatment failure rate of 21.1% (16/76 patients) was observed within a median follow-up of 2.6 years.
- No significant difference in failure rates was found between fluoroquinolone and non-fluoroquinolone groups.
- Elevated C-reactive protein levels (≥175 mg/L) were strongly associated with treatment failure (adjusted HR=7.75, P<0.0001).
Conclusions:
- Standardized management protocols may improve the prognosis of GNB-PJIs.
- Intravenous β-lactams, administered for 3 months, represent a viable alternative to fluoroquinolones for GNB-PJI treatment.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Endocarditis IV: Nursing Management
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Staphylococcal Skin Infections

